Citi Upgrades Abbvie (ABBV) to Buy
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $255.48 -1.03%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Citi upgraded Abbvie (NYSE: ABBV) from Neutral to Buy with a price target of $65.00.
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $55.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AbbVie seeks EMA approval for Skyrizi subcutaneous use in Crohn's
- Argus Upgrades Moderna (MRNA) to Buy
- Bradesco BBI Upgrades Petrobras (PBR) to Outperform
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
